Influence of antiestrogens on the migration of breast cancer cells using an in vitro wound model

Clinical and Experimental Metastasis

Volumn 15, Issue 4, 1997, Pages 393-399

  Mathew, Annie C ^a   Rajah, Talitha T ^a   Hurt, Gina M ^a   Abbas Abidi, S M ^a   Dmytryk, John J ^a   Pento, J Thomas ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Antiestrogens; Breast cancer cells; Cell migration; In vitro wounding

Indexed keywords

1,1 DICHLORO 2,3 DIPHENYLCYCLOPROPANE; ANTIESTROGEN; ANTIMETASTATIC AGENT; ESTRADIOL; FULVESTRANT; TAMOXIFEN;

ARTICLE; BREAST CANCER; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; MODEL; TUMOR CELL LINE; WOUND;

BREAST NEOPLASMS; CELL MOVEMENT; ESTRADIOL; ESTROGEN ANTAGONISTS; HUMANS; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0030789577     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018498120910     Document Type: Article

References (26)

1. Nicolson GL, 1988, Cancer metastasis - tumor cell and host organ properties important in colonization of specific secondary sites. Biochem Biophys Acta, 948, 175-224.
2. Dvorak HF, 1986, Tumors: wounds that do not heal. New Engl J Med, 315, 1650-9.
3. Jordan VC, 1993, A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol, 110, 507-17.
4. Clarke R, Thompson EW, Leonessa F, Lippman J, Frandsen TL and Brunner N, 1993, Hormone resistance, invasiveness, and metastatic potential in breast cancer. Breast Cancer Res Treat, 24, 227-39.
5. Leonessa F, Boulay V, Wright A, Thompson EW, Brunner N and Clarke R, 1992, The biology of breast tumor progression: acquistion of hormone independence and resistance to cytotoxic drugs. Acta Oncologica, 31, 115-23.
6. Thompson EW, Katz D, Shima TB, Wakeling AE, Lippman ME and Dickson RB, 1989, ICI-164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res, 49, 6929-34.
7. Levi-Schaffer F and Kupietzky A, 1990, Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Expt Cell Res, 188, 42-9.
8. Schleef RR and Birdwell CR, 1982, The effect on fibrin of endothelial cell migration in vitro. Tissue Cell, 14, 629-36.
9. Stewart RJ, Durley JA and Allardyce RA, 1979, The migration of fibroblasts into an in vitro wound. Br J Exptl Pathol, 60, 582-8.
10. Tchao R and Leighton J, 1979, The effect of vitamin A on the migration and DNA synthesis of rat bladder tumor cell line NBT II in culture. Invest Urol, 16, 478-82.
11. Jain PT, Pento JT, Magarian RA and Graves DC, 1991, Antiproliferative activity of a series of novel cyclopropyl antiestrogens on MCF-7 human breast cancer cells in culture. Anti-Cancer Drugs, 2, 487-93.
12. Jain PT, Pento JT and Magarian RA, 1994, A comparison of the antitumor activity of two triarylcyclopropyl antiestrogens (compounds 4d and 5c) on human breast cancer cells in culture. Anti-Cancer Drugs, 5, 429-36.
13. Burk RR, 1973, A factor from a transformed cell line that affects cell migration. Proc Natl Acad Sci USA, 70, 369-72.
14. Wakeling AE, 1993, The future of a new pure antiestrogen in clinical breast cancer. Breast Cancer Res Treat, 25, 1-9.
15. Pasqualini JR, Sumida C and Giambiagi N, 1988, Pharmacodynamics and biological effects of antiestrogens in different models. J Steroid Biochem, 31, 613-43.
16. Haar ET and Day BW, 1996, Cytostatic and cytotoxic action of Z-1,1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. Anticancer Res, 16, 1107-16.
17. Coradini D, Biffi A, Cappelletti V and DiFronzo G, 1994, Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells. Anticancer Res, 14, 1059-64.
18. Colletta AA, Benson JR and Baum M, 1994, Alternate mechanisms of action of anti-oestrogens. Breast Cancer Res Treat, 31, 5-9.
19. Manni A, Wright C and Buck H, 1991, Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res Treat, 20, 43-52.
20. Knabbe C, Lippman ME and Wakefield LM, 1987, Evidence that transforming growth factor is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48, 417-28.
21. Thompson EW, Reich R, Shima TB, et al. 1988, Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res, 48, 6764-8.
22. Knabe C, Zugmaier G, Schmahl M, Dietel M, Lippman ME and Dickson RB, 1991, Induction of TGF by antiestrogens droloxifene and toremifene in MCF-7 cells. Am J Clin Oncol, 14 (suppl 2), s15-s20.
23. Pento JT, Magarian RA, Wright RJ, King MM and Benjamin EJ, 1981, Non-steroidal estrogens and antiestrogens: biological activity of cyclopropyl analogs of stilbene and stilbenediol. J Pharm Sci, 70, 399-403.
24. Jain PT, Pento JT, Magarian RA and Graves DC, 1991, Cyto-toxicity of Analog II in human breast cancer cells in culture. The Toxicologist, 11, 157.
25. Vasiliev JM, Gelfand IM, Dominina LV and Rappoport RI, 1969, Wound healing processes in cell cultures. Expt Cell Res, 54, 83-93.
26. Brunner N, Boysen B, Romer J and Spang-Thomsen M, 1993, The Nude mouse as an in vivo model for breast cancer invasion and metastasis. Breast Cancer Res Treat, 24, 257-64.